WHO Grade 3 Glioma — Trials

WHO Grade 3 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 2
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (53)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03956706	Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas	withdrawn	N/A	0	Northwell HealthOTHER	1	Mar 15, 2023	clinicaltrials
NCT03353896	NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma	withdrawn	N/A	0	University of Southern CaliforniaOTHER	1	Dec 10, 2020	clinicaltrials